Introduction
Cimetidine, a Hz histamine receptor antagonist, has gained in popularity recently following its widespread use in patients with peptic ulcers, where it acts by reducing the acidity of the gastric secretions (Brogden et al. 1978) . It has been further suggested that it can be successfully used in situations such as in obstetric patients requiring anaesthesia (Dobb 1978 , Stoelting 1978 .The obvious rationale behind this is to reduce the incidence or severity of the pulmonary aspiration (Mendelson's) syndrome in the event of accidental aspiration of gastric contents.
However, it is important to remember that Hz histamine receptors have been shown to exist in the uterus (Stoelting 1978 , Blyth 1973 , Glover et al. 1973 in addition to being present in major arteries, arterioles and bronchi. Whereas the potential usefulness of cimetidine in obstetric patients is not doubted, one needs to be absolutely sure that it has no direct effect on the uterine tone. Similarly, one needs to be certain that cimetidine given intravenously in the recommended doses does not cause haemodynamic upsets which may indirectly jeopardize the safety of the mother and fetus.
Before embarking on a study of the effect of cimetidine on uterine tone (Dundee et al. 1979 ; McGowan, see p 902) and subsequent effects on the fetus, it was felt necessary to carry out haemodynamic measurements in non-pregnant patients. Furthermore, since cimetidine is often used in intensive care units in patients on long-term intravenous feeding, it was felt that a study of the effect on the cardiovascular system in these patients is both necessary and justifiable.
Methods
Ten adults, who required ventilation in the intensive care unit of the Royal Victoria Hospital, Belfast, were studied. Their ages ranged from 15 to 53 years (Table I) . All had a tracheostomy or a tracheal tube in situ and were requiring intermittent positive pressure ventilation with or without positive-end-expiratory pressure (PEEP). All received myoneural blocking drugs, analgesics and sedatives, but drugs with specific antihistamine properties were avoided. No medication was given in the hour prior to or during the study. No patient was in acute pain or distress and all were normovolaemic.
A cannula into the radial artery (18 swg) and Teflon catheter into the superior vena cava with its tip positioned just above the right atrium had been inserted at the time of admission for routine haemodynamic monitoring. The following were recorded: Arterial pressure: The radial artery catheter was connected to a strain-gauge (SE labs 4-88) and chart recorder (Elema-Schonander-Mingograf 34) following continuous recording. Central venous pressure (CVP): The catheter was connected to a saline manometer except during the injection of the dye. Electrocardiogram (ECG) : A simultaneous continuous record was made together with that of arterial pressure. Cardiac output: The Hamilton-Stewart dye dilution method (Kinsman et al. 1929 ) was used, employing indocyanine green as marker. Injection was made into the right atrium and sampling was from the radial artery. The dye-curves were analysed by a computer with a digital read out (COR 100, Waters Instruments Co). Blood gases: Arterial blood was sampled from the radial artery catheter into heparinized syringes and analysed immediately using a blood gas analyser (IL 413, Instrumentation Laboratories Ltd). Respiratory frequency and minute ventilation: These were not changed immediately prior to or during the study.
The protocol in each patient was: (I) control readings of arterial pressure, CVP, ECG, respiratory frequency and minute ventilation; (2) two, sometimes three, dye curves; (3) arterial blood sample for gas analysis; (4) cimetidine 400 mg injected, via the right atrial catheter, rapidly as a bolus; (5) The sequence of measurements (I and 2) was repeated at 5,15, 30 and 60 minutes following cimetidine injection. Table I shows the details of the patients studied. There were no significant changes in average heart rate, mean arterial pressure and central venous pressure following 400 mg cimetidine given intravenously (Table 2 ). However, one patient (3) had a fall in mean arterial pressure at 5 minutes after cimetidine injection and the pressure had not returned to normal in 60 minutes. This was one of two patients who required PEEP. 79  99  88  96  83  98  83  98  82  98  2  97  74  85  80  89  80  90  76  90  76  3  103 102  83  100  80  100  82  100  83  98  4  85  80  86  80  85  85  85  83  87  85  5  68  90  74  78  72  80  74  84  73  84  6  104 104  93  93  97  97  97  97  103 103  7  98 115  98  112  95  116  96  120  96 116  8  89 103  84  100  86  98  85  102  86 100  9  86  93  88  90  86  96  85  96  83  93  10  94  64  96  71  93  63  94 63 95 64 Figure I shows the individual cardiac output readings. The average control cardiac output was 7.II/min, which is slightly higher than the normal physiological level but not unexpected in patients with trauma. No significant changes in mean values were observed after cimetidine (Table 3) . However, the one patient referred to above had a greater than 30% reduction in cardiac output within 5 minutes of cimetidine injection. Subsequent measurements revealed consistently low values in this patient. 
Results

Discussion
On the basis of this short study, 400 mg cimetidine do not appear to embarrass the circulatory function, although we cannot explain why in one individual patient hypotension and a fall in cardiac output were seen. Other patients in the intensive care unit receiving similar doses of cimetidine did not show hypotension at any stage. It would appear that one patient was an exception to this. This is one of two patients who required PEEP to maintain adequate oxygenation and this may have been a contributory factor. However, in the light of the animal study of Altura & Halevy (1978) , cimetidine should be avoided in patients with circulatory shock. The present study has demonstrated the overall safety of cimetidine in recommended doses. These findings are in keeping with animal and volunteer studies carried out by Smith, Kline and French Laboratories (M J Boyce, personal communication).
Summary
Cardiac output was measured in 10 patients using the dye dilution method, before and after the intravenous injection of 400 mg cimetidine. The subjects were in the intensive care unit and required intermittent positive pressure ventilation. There was no change in the average blood pressure, heart rate and cardiac output during the 60 minutes following the cimetidine, although one patient showed a marked fall in cardiac output. The results suggest that cimetidine is without a marked depressant effect on cardiovascular system.
